A review now published in the Journal of Experimental & Clinical Cancer Research offers a sweeping and authoritative ...

GSK had just two months to celebrate the positive phase 3 result with its checkpoint inhibitor Jemperli as a first-line therapy for endometrial cancer, before Merck & Co crashed the party.

GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherapy option for first-line ...

Traditionally, punch biopsy sites have been sutured, but the benefit of this practice has never been scientifically demonstrated. In this prospective, randomized, method-comparison study ...

Unlike traditional biopsies that require cutting or inserting a needle to remove a piece of the tumour, a liquid biopsy only needs a small blood sample. Listen to Story A liquid biopsy is a test that ...